1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cell Therapy 1.2.3 Tissue Engineering 1.3 Market by Application 1.3.1 Global Cell Therapy and Tissue Engineering Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cell Defects 1.3.3 Genetic Diseases 1.3.4 Neurodegenerative Diseases 1.3.5 Tissue Malignancies 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cell Therapy and Tissue Engineering Market Perspective (2016-2027) 2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions 2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cell Therapy and Tissue Engineering Historic Market Share by Regions (2016-2021) 2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2022-2027) 2.3 Cell Therapy and Tissue Engineering Industry Dynamic 2.3.1 Cell Therapy and Tissue Engineering Market Trends 2.3.2 Cell Therapy and Tissue Engineering Market Drivers 2.3.3 Cell Therapy and Tissue Engineering Market Challenges 2.3.4 Cell Therapy and Tissue Engineering Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue 3.1.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue (2016-2021) 3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2016-2021) 3.2 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue 3.4 Global Cell Therapy and Tissue Engineering Market Concentration Ratio 3.4.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2020 3.5 Cell Therapy and Tissue Engineering Key Players Head office and Area Served 3.6 Key Players Cell Therapy and Tissue Engineering Product Solution and Service 3.7 Date of Enter into Cell Therapy and Tissue Engineering Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cell Therapy and Tissue Engineering Breakdown Data by Type 4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2016-2021) 4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2022-2027) 5 Cell Therapy and Tissue Engineering Breakdown Data by Application 5.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Application (2016-2021) 5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cell Therapy and Tissue Engineering Market Size (2016-2027) 6.2 North America Cell Therapy and Tissue Engineering Market Size by Type 6.2.1 North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) 6.2.2 North America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) 6.2.3 North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2027) 6.3 North America Cell Therapy and Tissue Engineering Market Size by Application 6.3.1 North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) 6.3.2 North America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) 6.3.3 North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2027) 6.4 North America Cell Therapy and Tissue Engineering Market Size by Country 6.4.1 North America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) 6.4.2 North America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Cell Therapy and Tissue Engineering Market Size (2016-2027) 7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type 7.2.1 Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) 7.2.2 Europe Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) 7.2.3 Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2027) 7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application 7.3.1 Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) 7.3.2 Europe Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) 7.3.3 Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2027) 7.4 Europe Cell Therapy and Tissue Engineering Market Size by Country 7.4.1 Europe Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) 7.4.2 Europe Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size (2016-2027) 8.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type 8.2.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2016-2027) 8.3 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application 8.3.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2016-2027) 8.4 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region 8.4.1 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cell Therapy and Tissue Engineering Market Size (2016-2027) 9.2 Latin America Cell Therapy and Tissue Engineering Market Size by Type 9.2.1 Latin America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) 9.2.2 Latin America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) 9.2.3 Latin America Cell Therapy and Tissue Engineering Market Size by Type (2016-2027) 9.3 Latin America Cell Therapy and Tissue Engineering Market Size by Application 9.3.1 Latin America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) 9.3.2 Latin America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) 9.3.3 Latin America Cell Therapy and Tissue Engineering Market Size by Application (2016-2027) 9.4 Latin America Cell Therapy and Tissue Engineering Market Size by Country 9.4.1 Latin America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) 9.4.2 Latin America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size (2016-2027) 10.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type 10.2.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2016-2027) 10.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application 10.3.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2016-2027) 10.4 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country 10.4.1 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Betalin Therapeutics 11.1.1 Betalin Therapeutics Company Details 11.1.2 Betalin Therapeutics Business Overview 11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction 11.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.1.5 Betalin Therapeutics Recent Development 11.2 BioCardia, Inc 11.2.1 BioCardia, Inc Company Details 11.2.2 BioCardia, Inc Business Overview 11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction 11.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.2.5 BioCardia, Inc Recent Development 11.3 BioReliance Corporation 11.3.1 BioReliance Corporation Company Details 11.3.2 BioReliance Corporation Business Overview 11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction 11.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.3.5 BioReliance Corporation Recent Development 11.4 Biosolution Co. 11.4.1 Biosolution Co. Company Details 11.4.2 Biosolution Co. Business Overview 11.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction 11.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.4.5 Biosolution Co. Recent Development 11.5 Brainstorm Cell Therapeutics, Inc 11.5.1 Brainstorm Cell Therapeutics, Inc Company Details 11.5.2 Brainstorm Cell Therapeutics, Inc Business Overview 11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 11.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.5.5 Brainstorm Cell Therapeutics, Inc Recent Development 11.6 MaxCyte, Inc 11.6.1 MaxCyte, Inc Company Details 11.6.2 MaxCyte, Inc Business Overview 11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction 11.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.6.5 MaxCyte, Inc Recent Development 11.7 Medigene AG 11.7.1 Medigene AG Company Details 11.7.2 Medigene AG Business Overview 11.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction 11.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.7.5 Medigene AG Recent Development 11.8 MEDIPOST CO. 11.8.1 MEDIPOST CO. Company Details 11.8.2 MEDIPOST CO. Business Overview 11.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction 11.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.8.5 MEDIPOST CO. Recent Development 11.9 Mesoblast Limited 11.9.1 Mesoblast Limited Company Details 11.9.2 Mesoblast Limited Business Overview 11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction 11.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.9.5 Mesoblast Limited Recent Development 11.10 Miromatrix Medical, Inc. 11.10.1 Miromatrix Medical, Inc. Company Details 11.10.2 Miromatrix Medical, Inc. Business Overview 11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction 11.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.10.5 Miromatrix Medical, Inc. Recent Development 11.11 MolMed S.p.A 11.11.1 MolMed S.p.A Company Details 11.11.2 MolMed S.p.A Business Overview 11.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction 11.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.11.5 MolMed S.p.A Recent Development 11.12 Mustang Bio, Inc 11.12.1 Mustang Bio, Inc Company Details 11.12.2 Mustang Bio, Inc Business Overview 11.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction 11.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.12.5 Mustang Bio, Inc Recent Development 11.13 NantKwest, Inc. 11.13.1 NantKwest, Inc. Company Details 11.13.2 NantKwest, Inc. Business Overview 11.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction 11.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.13.5 NantKwest, Inc. Recent Development 11.14 Neuralstem, Inc 11.14.1 Neuralstem, Inc Company Details 11.14.2 Neuralstem, Inc Business Overview 11.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction 11.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.14.5 Neuralstem, Inc Recent Development 11.15 NexImmune, Inc. 11.15.1 NexImmune, Inc. Company Details 11.15.2 NexImmune, Inc. Business Overview 11.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction 11.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.15.5 NexImmune, Inc. Recent Development 11.16 Nohla Therapeutics, Inc 11.16.1 Nohla Therapeutics, Inc Company Details 11.16.2 Nohla Therapeutics, Inc Business Overview 11.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 11.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.16.5 Nohla Therapeutics, Inc Recent Development 11.17 ReNeuron Group plc 11.17.1 ReNeuron Group plc Company Details 11.17.2 ReNeuron Group plc Business Overview 11.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction 11.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.17.5 ReNeuron Group plc Recent Development 11.18 Richter-Helm BioLogics GmbH & Co. KG 11.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details 11.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview 11.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction 11.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development 11.18 RoosterBio, Inc 11.25.1 RoosterBio, Inc Company Details 11.25.2 RoosterBio, Inc Business Overview 11.25.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction 11.25.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.25.5 RoosterBio, Inc Recent Development 11.20 RoslinCT 11.20.1 RoslinCT Company Details 11.20.2 RoslinCT Business Overview 11.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction 11.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.20.5 RoslinCT Recent Development 11.21 Rubius Therapeutics, Inc. 11.21.1 Rubius Therapeutics, Inc. Company Details 11.21.2 Rubius Therapeutics, Inc. Business Overview 11.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction 11.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.21.5 Rubius Therapeutics, Inc. Recent Development 11.22 Sangamo Therapeutics, Inc 11.22.1 Sangamo Therapeutics, Inc Company Details 11.22.2 Sangamo Therapeutics, Inc Business Overview 11.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 11.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.22.5 Sangamo Therapeutics, Inc Recent Development 11.23 Voyager Therapeutics, Inc 11.23.1 Voyager Therapeutics, Inc Company Details 11.23.2 Voyager Therapeutics, Inc Business Overview 11.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction 11.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.23.5 Voyager Therapeutics, Inc Recent Development 11.24 Waisman Biomanufacturing 11.24.1 Waisman Biomanufacturing Company Details 11.24.2 Waisman Biomanufacturing Business Overview 11.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction 11.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.24.5 Waisman Biomanufacturing Recent Development 11.25 WindMIL Therapeutics, Inc. 11.25.1 WindMIL Therapeutics, Inc. Company Details 11.25.2 WindMIL Therapeutics, Inc. Business Overview 11.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction 11.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.25.5 WindMIL Therapeutics, Inc. Recent Development 11.26 Wuxi App Tec, Inc. 11.26.1 Wuxi App Tec, Inc. Company Details 11.26.2 Wuxi App Tec, Inc. Business Overview 11.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction 11.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.26.5 Wuxi App Tec, Inc. Recent Development 11.27 ReNeuron Group plc 11.27.1 ReNeuron Group plc Company Details 11.27.2 ReNeuron Group plc Business Overview 11.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction 11.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.27.5 ReNeuron Group plc Recent Development 11.28 Richter-Helm BioLogics GmbH & Co. KG 11.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details 11.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview 11.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction 11.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development 11.29 RoosterBio, Inc 11.29.1 RoosterBio, Inc Company Details 11.29.2 RoosterBio, Inc Business Overview 11.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction 11.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.29.5 RoosterBio, Inc Recent Development 11.30 RoslinCT 11.30.1 RoslinCT Company Details 11.30.2 RoslinCT Business Overview 11.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction 11.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) 11.30.5 RoslinCT Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cell Therapy Table 3. Key Players of Tissue Engineering Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Cell Therapy and Tissue Engineering Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Cell Therapy and Tissue Engineering Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Cell Therapy and Tissue Engineering Market Share by Regions (2016-2021) Table 8. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Cell Therapy and Tissue Engineering Market Share by Regions (2022-2027) Table 10. Cell Therapy and Tissue Engineering Market Trends Table 11. Cell Therapy and Tissue Engineering Market Drivers Table 12. Cell Therapy and Tissue Engineering Market Challenges Table 13. Cell Therapy and Tissue Engineering Market Restraints Table 14. Global Cell Therapy and Tissue Engineering Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Cell Therapy and Tissue Engineering Market Share by Players (2016-2021) Table 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020) Table 17. Ranking of Global Top Cell Therapy and Tissue Engineering Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Cell Therapy and Tissue Engineering Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Cell Therapy and Tissue Engineering Product Solution and Service Table 21. Date of Enter into Cell Therapy and Tissue Engineering Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million) Table 24. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2016-2021) Table 25. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Cell Therapy and Tissue Engineering Revenue Market Share by Application (2016-2021) Table 29. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Cell Therapy and Tissue Engineering Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million) Table 32. North America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million) Table 34. North America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Cell Therapy and Tissue Engineering Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Country (2022-2027) & (US$ Million) Table 61. Betalin Therapeutics Company Details Table 62. Betalin Therapeutics Business Overview Table 63. Betalin Therapeutics Cell Therapy and Tissue Engineering Product Table 64. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 65. Betalin Therapeutics Recent Development Table 66. BioCardia, Inc Company Details Table 67. BioCardia, Inc Business Overview Table 68. BioCardia, Inc Cell Therapy and Tissue Engineering Product Table 69. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 70. BioCardia, Inc Recent Development Table 71. BioReliance Corporation Company Details Table 72. BioReliance Corporation Business Overview Table 73. BioReliance Corporation Cell Therapy and Tissue Engineering Product Table 74. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 75. BioReliance Corporation Recent Development Table 76. Biosolution Co. Company Details Table 77. Biosolution Co. Business Overview Table 78. Biosolution Co. Cell Therapy and Tissue Engineering Product Table 79. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 80. Biosolution Co. Recent Development Table 81. Brainstorm Cell Therapeutics, Inc Company Details Table 82. Brainstorm Cell Therapeutics, Inc Business Overview Table 83. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Table 84. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 85. Brainstorm Cell Therapeutics, Inc Recent Development Table 86. MaxCyte, Inc Company Details Table 87. MaxCyte, Inc Business Overview Table 88. MaxCyte, Inc Cell Therapy and Tissue Engineering Product Table 89. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 90. MaxCyte, Inc Recent Development Table 91. Medigene AG Company Details Table 92. Medigene AG Business Overview Table 93. Medigene AG Cell Therapy and Tissue Engineering Product Table 94. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 95. Medigene AG Recent Development Table 96. MEDIPOST CO. Company Details Table 97. MEDIPOST CO. Business Overview Table 98. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 99. MEDIPOST CO. Recent Development Table 100. Mesoblast Limited Company Details Table 101. Mesoblast Limited Business Overview Table 102. Mesoblast Limited Cell Therapy and Tissue Engineering Product Table 103. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 104. Mesoblast Limited Recent Development Table 105. Miromatrix Medical, Inc. Company Details Table 106. Miromatrix Medical, Inc. Business Overview Table 107. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Table 108. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 109. Miromatrix Medical, Inc. Recent Development Table 110. MolMed S.p.A Company Details Table 111. MolMed S.p.A Business Overview Table 112. MolMed S.p.A Cell Therapy and Tissue Engineering Product Table 113. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 114. MolMed S.p.A Recent Development Table 115. Mustang Bio, Inc Company Details Table 116. Mustang Bio, Inc Business Overview Table 117. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Table 118. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 119. Mustang Bio, Inc Recent Development Table 120. NantKwest, Inc. Company Details Table 121. NantKwest, Inc. Business Overview Table 122. NantKwest, Inc. Cell Therapy and Tissue Engineering Product Table 123. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 124. NantKwest, Inc. Recent Development Table 125. Neuralstem, Inc Company Details Table 126. Neuralstem, Inc Business Overview Table 127. Neuralstem, Inc Cell Therapy and Tissue Engineering Product Table 128. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 129. Neuralstem, Inc Recent Development Table 130. NexImmune, Inc. Company Details Table 131. NexImmune, Inc. Business Overview Table 132. NexImmune, Inc. Cell Therapy and Tissue Engineering Product Table 133. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 134. NexImmune, Inc. Recent Development Table 135. Nohla Therapeutics, Inc Company Details Table 136. Nohla Therapeutics, Inc Business Overview Table 137. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Table 138. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 139. Nohla Therapeutics, Inc Recent Development Table 140. ReNeuron Group plc Company Details Table 141. ReNeuron Group plc Business Overview Table 142. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Table 143. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 144. ReNeuron Group plc Recent Development Table 145. Richter-Helm BioLogics GmbH & Co. KG Company Details Table 146. Richter-Helm BioLogics GmbH & Co. KG Business Overview Table 147. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Table 148. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 149. Richter-Helm BioLogics GmbH & Co. KG Recent Development Table 150. RoosterBio, Inc Company Details Table 151. RoosterBio, Inc Business Overview Table 152. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Table 153. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 154. RoosterBio, Inc Recent Development Table 155. RoslinCT Company Details Table 156. RoslinCT Business Overview Table 157. RoslinCT Cell Therapy and Tissue Engineering Product Table 158. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 159. RoslinCT Recent Development Table 160. Rubius Therapeutics, Inc. Company Details Table 161. Rubius Therapeutics, Inc. Business Overview Table 162. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Table 163. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 164. Rubius Therapeutics, Inc. Recent Development Table 165. Sangamo Therapeutics, Inc Company Details Table 166. Sangamo Therapeutics, Inc Business Overview Table 167. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Table 168. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 169. Sangamo Therapeutics, Inc Recent Development Table 170. Voyager Therapeutics, Inc Company Details Table 171. Voyager Therapeutics, Inc Business Overview Table 172. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Table 173. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 174. Voyager Therapeutics, Inc Recent Development Table 175. Waisman Biomanufacturing Company Details Table 176. Waisman Biomanufacturing Business Overview Table 177. Waisman Biomanufacturing Cell Therapy and Tissue EngineeringProduct Table 178. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 179. Waisman Biomanufacturing Recent Development Table 180. WindMIL Therapeutics, Inc. Company Details Table 181. WindMIL Therapeutics, Inc. Business Overview Table 182. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Table 183. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 184. WindMIL Therapeutics, Inc. Recent Development Table 185. Wuxi App Tec, Inc. Company Details Table 186. Wuxi App Tec, Inc. Business Overview Table 187. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Table 188. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 189. Wuxi App Tec, Inc. Recent Development Table 190. ReNeuron Group plc Company Details Table 191. ReNeuron Group plc Business Overview Table 192. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Table 193. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 194. ReNeuron Group plc Recent Development Table 195. Richter-Helm BioLogics GmbH & Co. KG Company Details Table 196. Richter-Helm BioLogics GmbH & Co. KG Business Overview Table 197. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Table 198. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 199. Richter-Helm BioLogics GmbH & Co. KG Recent Development Table 200. RoosterBio, Inc Company Details Table 201. RoosterBio, Inc Business Overview Table 202. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Table 203. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 204. RoosterBio, Inc Recent Development Table 205. RoslinCT Company Details Table 206. RoslinCT Business Overview Table 207. RoslinCT Cell Therapy and Tissue Engineering Product Table 208. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2016-2021) & (US$ Million) Table 209. RoslinCT Recent Development Table 210. Research Programs/Design for This Report Table 211. Key Data Information from Secondary Sources Table 212. Key Data Information from Primary Sources List of Figures Figure 1. Global Cell Therapy and Tissue Engineering Market Share by Type: 2020 VS 2027 Figure 2. Cell Therapy Features Figure 3. Tissue Engineering Features Figure 4. Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2027 Figure 5. Cell Defects Case Studies Figure 6. Genetic Diseases Case Studies Figure 7. Neurodegenerative Diseases Case Studies Figure 8. Tissue Malignancies Case Studies Figure 9. Others Case Studies Figure 10. Cell Therapy and Tissue Engineering Report Years Considered Figure 11. Global Cell Therapy and Tissue Engineering Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Cell Therapy and Tissue Engineering Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Cell Therapy and Tissue Engineering Market Share by Regions: 2020 VS 2027 Figure 14. Global Cell Therapy and Tissue Engineering Market Share by Regions (2022-2027) Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Players in 2020 Figure 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2020 Figure 18. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2016-2021) Figure 19. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2022-2027) Figure 20. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Cell Therapy and Tissue Engineering Market Share by Type (2016-2027) Figure 22. North America Cell Therapy and Tissue Engineering Market Share by Application (2016-2027) Figure 23. North America Cell Therapy and Tissue Engineering Market Share by Country (2016-2027) Figure 24. United States Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Cell Therapy and Tissue Engineering Market Share by Type (2016-2027) Figure 28. Europe Cell Therapy and Tissue Engineering Market Share by Application (2016-2027) Figure 29. Europe Cell Therapy and Tissue Engineering Market Share by Country (2016-2027) Figure 30. Germany Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Cell Therapy and Tissue Engineering Market Share by Type (2016-2027) Figure 38. Asia-Pacific Cell Therapy and Tissue Engineering Market Share by Application (2016-2027) Figure 39. Asia-Pacific Cell Therapy and Tissue Engineering Market Share by Region (2016-2027) Figure 40. China Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Cell Therapy and Tissue Engineering Market Share by Type (2016-2027) Figure 48. Latin America Cell Therapy and Tissue Engineering Market Share by Application (2016-2027) Figure 49. Latin America Cell Therapy and Tissue Engineering Market Share by Country (2016-2027) Figure 50. Mexico Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Cell Therapy and Tissue Engineering Market Share by Type (2016-2027) Figure 54. Middle East & Africa Cell Therapy and Tissue Engineering Market Share by Application (2016-2027) Figure 55. Middle East & Africa Cell Therapy and Tissue Engineering Market Share by Country (2016-2027) Figure 56. Turkey Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Cell Therapy and Tissue Engineering Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 60. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 61. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 62. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 63. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 64. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 65. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 66. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 67. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 68. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 69. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 70. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 71. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 72. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 73. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 74. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 75. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 76. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 77. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 78. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 79. Rubius Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 80. Sangamo Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 81. Voyager Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 82. Waisman Biomanufacturing Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 83. WindMIL Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 84. Wuxi App Tec, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 85. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 86. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 87. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 88. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2016-2021) Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

Betalin Therapeutics BioCardia, Inc BioReliance Corporation Biosolution Co. Brainstorm Cell Therapeutics, Inc MaxCyte, Inc Medigene AG MEDIPOST CO. Mesoblast Limited Miromatrix Medical, Inc. MolMed S.p.A Mustang Bio, Inc NantKwest, Inc. Neuralstem, Inc NexImmune, Inc. Nohla Therapeutics, Inc ReNeuron Group plc Richter-Helm BioLogics GmbH & Co. KG RoosterBio, Inc RoslinCT Rubius Therapeutics, Inc. Sangamo Therapeutics, Inc Voyager Therapeutics, Inc Waisman Biomanufacturing WindMIL Therapeutics, Inc. Wuxi App Tec, Inc. ReNeuron Group plc Richter-Helm BioLogics GmbH & Co. KG RoosterBio, Inc RoslinCT